Selective effects of hydroxyapatite nanoparticles on osteosarcoma cells and osteoblasts

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 9, 2012, Pages 2245-2251

  Qing, Fangzhu ^a   Wang, Zhe ^a   Hong, Youliang ^a   Liu, Ming ^a   Guo, Bo ^b   Luo, Hongrong ^a   Zhang, Xingdong ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE CELLS; FLUORESCENT STAINING; MG63 CELLS; MTT ASSAYS; OSTEOSARCOMA CELLS; TRANSMISSION ELECTRON MICROSCOPY TEM;

CELL CULTURE; CELL DEATH; HYDROXYAPATITE; NANOPARTICLES; TRANSMISSION ELECTRON MICROSCOPY;

OSTEOBLASTS;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FLUORESCENT DYE; HYDROXYAPATITE; NANOPARTICLE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

BONE NEOPLASMS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DURAPATITE; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; ORGAN SPECIFICITY; ORGANELLES; OSTEOBLASTS; OSTEOSARCOMA;

EID: 84867102149     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4703-6     Document Type: Article

References (14)

1. Scheel J, Hermann M. Integrated risk assessment of a hydroxyapatite- protein-composite for use in oral care products: a weight-ofevidence case study. Regul Toxicol Pharm. 2011;59(2):310-23.
2. Alcaide M, Serrano M-C, Pagani R, Sánchez-Salcedo S, Vallet-Regí M, Portolés M-T. Biocompatibility markers for the study of interactions between osteoblasts and composite biomaterials. Biomaterials. 2009;30(1):45-51.
3. Marulanda GA, Henderson ER, Johnson DA, Letson GD, Cheong D. Orthopedic surgery options for the treatment of primary osteosarcoma. Cancer Control. 2008;15(1):13-20.
4. Daculsi G, Hartmann D, Heughebaert M, Hamel L, Le Nihouannen J. In vivo cell interactions with calcium phosphate bioceramics. J Submicrosc Cytol Pathol. 1988;20(2):379-84.
5. Li B, Chen X, Guo B, Wang X, Fan H, Zhang X. Fabrication and cellular biocompatibility of porous carbonated biphasic calcium phosphate ceramics with a nanostructure. Acta Biomater. 2009; 5(1):134-43.
6. Hong Y, Fan H, Li B, Guo B, Liu M, Zhang X. Fabrication, biological effects, and medical applications of calcium phosphate nanoceramics. Mater Sci Eng, R. 2010;70(3-6):225-42.
7. Li B, Guo B, Fan H, Zhang X. Preparation of nano-hydroxyapatite particles with different morphology and their response to highly malignant melanoma cells in vitro. Appl Surf Sci. 2008; 255(2):357-60.
8. Yuan Y, Liu C, Qian J, Wang J, Zhang Y. Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells. Biomaterials. 2010;31(4):730-40.
9. Motskin M, Wright DM, Muller K, Kyle N, Gard TG, Porter AE, Skepper JN. Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostability. Biomaterials. 2009;30(19):3307-17.
10. Shi Z, Huang X, Liu B, Tao H, Cai Y, Tang R. Biological response of osteosarcoma cells to size-controlled nanostructured hydroxyapatite. J Biomater Appl. 2010;25(1):19-37.
11. Shi Z, Huang X, Cai Y, Tang R, Yang D. Size effect of hydroxyapatite nanoparticles on proliferation and apoptosis of osteoblast-like cells. Acta Biomater. 2009;5(1):338-45.
12. Yamazaki K, Nakashima H, Eyden BP, Sakai T, Omae K, Sakurai H. Acute renal injury by tetraethyl orthosilicate in mice: ultrastructure, histochemistry and X-ray microanalysis. J Submicrosc Cytol Pathol. 1992;24(2):257-68.
13. Bignold LP, Moore L, Mukherjee TM. Adenocarcinoma of rectosigmoid colon. Ultrastruct Pathol. 1988;12(5):569-75.
14. Ahlstrom M, Pekkinen M, Riehle U, Lamberg-Allardt C. Extracellular calcium regulates parathyroid hormone-related peptide expression in osteoblasts and osteoblast progenitor cells. Bone. 2008;42:483-90.